Seretide for obstructive lung disease

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.3, Iss.3, 2002-03, pp. : 341-350

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the issues in chronic obstructive lung disease

By Berry Jean

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 1, 2003-05 ,pp. : 83-92

Informa Healthcare

Access to resources Recommend Favorite

Chronic obstructive pulmonary disease: consequences beyond the lung

By Shrikrishna Dinesh Hopkinson Nicholas S

Clinical Medicine, Vol. 12, Iss. 1, 2012-02 ,pp. : 71-74

Royal College Of Physicians

Access to resources Recommend Favorite

Inhaled 2-Adrenoceptor Agonists: Cardiovascular Safety in Patients with Obstructive Lung Disease

By Cazzola Mario

Drugs, Vol. 65, Iss. 12, 2005-01 ,pp. : 1595-1610

Adis International

Access to resources Recommend Favorite

From Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guidelines to Current Clinical Practice: An Overview of the Pharmacological Therapy of Stable Chronic Obstructive Pulmonary Disorder

By Raffaele Antonelli Incalzi

Drugs & Aging, Vol. 23, Iss. 5, 2006-01 ,pp. : 411-420

Adis International

Access to resources Recommend Favorite

What Defines Abnormal Lung Function in Older Adults with Chronic Obstructive Pulmonary Disease?

By Bhatt Nitin Y. Wood Karen L.

Drugs & Aging, Vol. 25, Iss. 9, 2008-01 ,pp. : 717-728

Adis International

Access to resources Recommend Favorite